Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1981 1
1982 1
1983 1
1984 3
1985 1
1990 1
1991 2
1992 1
1993 5
1994 3
1995 3
1996 2
1997 4
1998 2
1999 2
2000 1
2001 4
2002 2
2003 3
2004 7
2005 5
2006 13
2007 7
2008 11
2009 6
2010 12
2011 11
2012 14
2013 23
2014 38
2015 51
2016 42
2017 61
2018 66
2019 61
2020 82
2021 81
2022 90
2023 100
2024 45

Text availability

Article attribute

Article type

Publication date

Search Results

719 results

Results by year

Filters applied: . Clear all
Page 1
Red Blood Cell Transfusion: 2023 AABB International Guidelines.
Carson JL, Stanworth SJ, Guyatt G, Valentine S, Dennis J, Bakhtary S, Cohn CS, Dubon A, Grossman BJ, Gupta GK, Hess AS, Jacobson JL, Kaplan LJ, Lin Y, Metcalf RA, Murphy CH, Pavenski K, Prochaska MT, Raval JS, Salazar E, Saifee NH, Tobian AAR, So-Osman C, Waters J, Wood EM, Zantek ND, Pagano MB. Carson JL, et al. JAMA. 2023 Nov 21;330(19):1892-1902. doi: 10.1001/jama.2023.12914. JAMA. 2023. PMID: 37824153
OBJECTIVE: To provide recommendations for use of red blood cell transfusion in adults and children. EVIDENCE REVIEW: Standards for trustworthy guidelines were followed, including using Grading of Recommendations Assessment, Development and Evaluation methods, managing conf …
OBJECTIVE: To provide recommendations for use of red blood cell transfusion in adults and children. EVIDENCE REVIEW: Standards for tr …
The 2023 International Society for Heart and Lung Transplantation Guidelines for Mechanical Circulatory Support: A 10- Year Update.
Saeed D, Feldman D, Banayosy AE, Birks E, Blume E, Cowger J, Hayward C, Jorde U, Kremer J, MacGowan G, Maltais S, Maybaum S, Mehra M, Shah KB, Mohacsi P, Schweiger M, Schroeder SE, Shah P, Slepian M, Tops LF, Alvarez P, Arabia F, Aslam S, Benson-Louis L 4th, Birati E, Buchholz HW, Cedars A, Christensen D, Ciarka A, Coglianese E, Cogswell R, Cook J, Copeland J, Costello JG, Drakos SG, Eghtesady P, Elliot T, Estep JD, Eulert-Grehn JJ, Fabrizio R, Garbade J, Gelow J, Guglin M, Hernandez-Montfort J, Horstmanshof D, John R, Kanwar M, Khaliel F, Kim G, Kumar S, Lavee J, Leache M, Leprince P, Lim S, Loforte A, Maly J, Najjar S, Netuka I, Pamboukian SV, Patel SR, Pinney S, Pluym CV, Potapov E, Robson D, Rochlani Y, Russell S, Sandau K, Sandoval E, Sayer G, Schettle S, Schibilsky D, Schlöglhofer T, Schmitto J, Siddique A, Silvestry S, Slaughter MS, Sun B, Takayama H, Tedford R, Teuteberg JJ, Ton VK, Uriel N, Vierecke J, Zimpfer D, D'Alessandro D. Saeed D, et al. J Heart Lung Transplant. 2023 Jul;42(7):e1-e222. doi: 10.1016/j.healun.2022.12.004. Epub 2023 May 25. J Heart Lung Transplant. 2023. PMID: 37245143 No abstract available.
Inducible apoptosis as a safety switch for adoptive cell therapy.
Di Stasi A, Tey SK, Dotti G, Fujita Y, Kennedy-Nasser A, Martinez C, Straathof K, Liu E, Durett AG, Grilley B, Liu H, Cruz CR, Savoldo B, Gee AP, Schindler J, Krance RA, Heslop HE, Spencer DM, Rooney CM, Brenner MK. Di Stasi A, et al. N Engl J Med. 2011 Nov 3;365(18):1673-83. doi: 10.1056/NEJMoa1106152. N Engl J Med. 2011. PMID: 22047558 Free PMC article. Clinical Trial.
RESULTS: Five patients between the ages of 3 and 17 years who had undergone stem-cell transplantation for relapsed acute leukemia were treated with the genetically modified T cells. ...CONCLUSIONS: The iCasp9 cell-suicide system may increase the safety of cellular therapie …
RESULTS: Five patients between the ages of 3 and 17 years who had undergone stem-cell transplantation for relapsed acute leukemia wer …
2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients.
Writing Committee Members; Shah MJ, Silka MJ, Silva JNA, Balaji S, Beach CM, Benjamin MN, Berul CI, Cannon B, Cecchin F, Cohen MI, Dalal AS, Dechert BE, Foster A, Gebauer R, Gonzalez Corcia MC, Kannankeril PJ, Karpawich PP, Kim JJ, Krishna MR, Kubuš P, LaPage MJ, Mah DY, Malloy-Walton L, Miyazaki A, Motonaga KS, Niu MC, Olen M, Paul T, Rosenthal E, Saarel EV, Silvetti MS, Stephenson EA, Tan RB, Triedman J, Bergen NHV, Wackel PL. Writing Committee Members, et al. Heart Rhythm. 2021 Nov;18(11):1888-1924. doi: 10.1016/j.hrthm.2021.07.038. Epub 2021 Jul 29. Heart Rhythm. 2021. PMID: 34363988 Free article.
The recommendations were opened for public comment to Pediatric and Congenital Electrophysiology Society (PACES) members and underwent external review by the scientific and clinical document committee of the Heart Rhythm Society (HRS), the science advisory and coordinating …
The recommendations were opened for public comment to Pediatric and Congenital Electrophysiology Society (PACES) members and underwent exter …
Waitlist and post-transplant outcomes for children with myocarditis listed for heart transplantation over 3 decades.
Amdani S, Korang AA, Law Y, Cantor R, Koehl D, Kirklin JK, Ybarra M, Rusconi P, Azeka E, Ruiz ACP, Schowengerdt K, Bostdorff H, Joong A. Amdani S, et al. J Heart Lung Transplant. 2023 Jan;42(1):89-99. doi: 10.1016/j.healun.2022.07.013. Epub 2022 Jul 21. J Heart Lung Transplant. 2023. PMID: 36038480
BACKGROUND: There is limited and conflicting information on waitlist and transplant outcomes for children with myocarditis. METHODS: Retrospective review included children with myocarditis and dilated cardiomyopathy (DCM) listed for HT from January 01, 1993 t …
BACKGROUND: There is limited and conflicting information on waitlist and transplant outcomes for children with myocarditis. ME …
Hospitalisations of children and adults with Hypoplastic Left Heart Syndrome in Texas from 2009 to 2019.
Well A, Dawson C, Johnson G, Patt H, Fraser CD, Mery CM, Beckerman Z. Well A, et al. Cardiol Young. 2023 Oct;33(10):1819-1827. doi: 10.1017/S1047951122003146. Epub 2022 Oct 12. Cardiol Young. 2023. PMID: 36220311
This study evaluates number of, reasons for, and trends in discharges of patients with hypoplastic left heart syndrome over 11 years in Texas. METHODS: The Texas Inpatient Discharge Dataset Public Use File captures almost all discharges in Texas and wa …
This study evaluates number of, reasons for, and trends in discharges of patients with hypoplastic left heart syndrome over 11 years …
Morbidity and Mortality in Adult Fontan Patients After Heart or Combined Heart-Liver Transplantation.
Lewis MJ, Reardon LC, Aboulhosn J, Haeffele C, Chen S, Kim Y, Fuller S, Forbess L, Alshawabkeh L, Urey MA, Book WM, Rodriguez F 3rd, Menachem JN, Clark DE, Valente AM, Carazo M, Egbe A, Connolly HM, Krieger EV, Angiulo J, Cedars A, Ko J, Jacobsen RM, Earing MG, Cramer JW, Ermis P, Broda C, Nugaeva N, Ross H, Awerbach JD, Krasuski RA, Rosenbaum M. Lewis MJ, et al. J Am Coll Cardiol. 2023 Jun 6;81(22):2161-2171. doi: 10.1016/j.jacc.2023.03.422. J Am Coll Cardiol. 2023. PMID: 37257951
BACKGROUND: An increasing number of adult Fontan patients require heart transplantation (HT) or combined heart-liver transplant (CHLT); however, data regarding outcomes and optimal referral time remain limited. ...Date of "failing" Fontan was defined a …
BACKGROUND: An increasing number of adult Fontan patients require heart transplantation (HT) or combined heart-liver …
Selection and Interpretation of Molecular Diagnostics in Heart Transplantation.
Goldberg JF, Truby LK, Agbor-Enoh S, Jackson AM, deFilippi CR, Khush KK, Shah P. Goldberg JF, et al. Circulation. 2023 Aug 22;148(8):679-694. doi: 10.1161/CIRCULATIONAHA.123.062847. Epub 2023 Aug 21. Circulation. 2023. PMID: 37603604 Review.
This review aims to provide an overview of biomarker and immunologic tests used to diagnose posttransplant complications. This includes a discussion of pediatric heart transplantation and the disparate rates of rejection and death experienced by Black patients recei …
This review aims to provide an overview of biomarker and immunologic tests used to diagnose posttransplant complications. This includes a di …
Hospital outcomes for pediatric heart transplant recipients undergoing tracheostomy: A multi-institutional analysis.
Spinner JA, Denfield SW, Puri K, Morris SA, Costello JM, Moffett BS, Wang Y, Shekerdemian LS, Tunuguntla HP, Price JF, Heinle JS, Adachi I, Dreyer WJ, Cabrera AG. Spinner JA, et al. Pediatr Transplant. 2021 May;25(3):e13904. doi: 10.1111/petr.13904. Epub 2020 Nov 11. Pediatr Transplant. 2021. PMID: 33179431
Tracheostomy is associated with increased mortality and resource utilization in children with CHD. However, the prevalence and hospital outcomes of tracheostomy in children with HTx are not known. ...Pre-TT was not independently associated with increased post …
Tracheostomy is associated with increased mortality and resource utilization in children with CHD. However, the prevalence and hos …
Heart Transplantation in Children With Down Syndrome.
Godown J, Fountain D, Bansal N, Ameduri R, Anderson S, Beasley G, Burstein D, Knecht K, Molina K, Pye S, Richmond M, Spinner JA, Watanabe K, West S, Reinhardt Z, Scheel J, Urschel S, Villa C, Hollander SA. Godown J, et al. J Am Heart Assoc. 2022 May 17;11(10):e024883. doi: 10.1161/JAHA.121.024883. Epub 2022 May 16. J Am Heart Assoc. 2022. PMID: 35574952 Free PMC article.
Background Children with Down syndrome (DS) have a high risk of cardiac disease that may prompt consideration for heart transplantation (HTx). ...A total of 23 (88%) patients survived to transplant. All transplanted patients survived to hospi …
Background Children with Down syndrome (DS) have a high risk of cardiac disease that may prompt consideration for heart tra …
719 results